Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene

被引:56
作者
Kirkwood, SC
Siemers, E
Bond, C
Conneally, PM
Christian, JC
Foroud, T
机构
[1] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
10.1001/archneur.57.7.1040
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To confirm that subtle changes in motor function and reaction time are present in presymptomatic individuals carrying the expanded Huntington disease (HD) allele. Design: A case-control, double-blind study comparing presymptomatic HD gene carriers (PSGCs)and non-gene carriers (NGCs) at risk for HD. Setting: The Department of Medical and Molecular Genetics at a general clinical research center in a midwestern city. Participants: Two hundred sixteen individuals at risk for HD who were asymptomatic by self-report and who did not have manifest HD on results of clinical examination, including PSGCs (n=61) and NGCs (n=155). Measures: Molecular testing was used to determine the number of CAG repeats in the HD gene. A quantified neurologic examination and a battery of physiological measures of central nervous system function measuring speed of movement and reaction time were administered. Results: On neurologic examination, the PSGCs exhibited significantly more definite or possible abnormalities than NGCs for overall oculomotor function, saccade velocity, optokinetic nystagmus, chorea of the extremities, and dystonia of the extremities (P<.05). The PSGCs also had significantly slower performance for auditory reaction time, visual reaction time, visual reaction time with decision, movement time, movement time with decision, and button-lapping time, compared with the NGCs (P<.05). Conclusions: Subtle changes in motor function, speed of movement, and reaction time are present in HD gene carriers who do not exhibit definite choreiform movements and who do not have sufficient signs to make a clinical diagnosis of PID. In addition, a trend toward slower speed of movement and reaction time was observed among this population as their neurologic abnormalities increased.
引用
收藏
页码:1040 / 1044
页数:5
相关论文
共 23 条
[1]   THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].
ANDREW, SE ;
GOLDBERG, YP ;
KREMER, B ;
TELENIUS, H ;
THEILMANN, J ;
ADAM, S ;
STARR, E ;
SQUITIERI, F ;
LIN, BY ;
KALCHMAN, MA ;
GRAHAM, RK ;
HAYDEN, MR .
NATURE GENETICS, 1993, 4 (04) :398-403
[2]  
[Anonymous], 1981, Statistical Tables
[3]   THE DIAGNOSTIC-VALUE OF EYE-MOVEMENT RECORDINGS IN PATIENTS WITH HUNTINGTONS-DISEASE AND THEIR OFFSPRING [J].
BEENEN, N ;
BUTTNER, U ;
LANGE, HW .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1986, 63 (02) :119-127
[4]  
Bond CE, 1996, CLIN CHEM, V42, P773
[5]   OCULOMOTOR DEFECTS IN PATIENTS WITH HUNTINGTONS-DISEASE AND THEIR OFFSPRING [J].
COLLEWIJN, H ;
WENT, LN ;
TAMMINGA, EP ;
VEGTERVANDERVLIS, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1988, 86 (2-3) :307-320
[6]   Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease [J].
deBoo, GM ;
Tibben, A ;
Lanser, JBK ;
JennekensSchinkel, A ;
Hermans, J ;
MaatKievit, A ;
Roos, RAC .
ARCHIVES OF NEUROLOGY, 1997, 54 (11) :1353-1357
[7]  
FOLSTEIN SE, 1983, NEUROBEH TOXICOL TER, V5, P605
[8]  
Folstein SE, 1989, HUNTINGTONS DIS DISO
[9]   COGNITIVE SCORES IN CARRIERS OF HUNTINGTONS-DISEASE GENE COMPARED TO NONCARRIERS [J].
FOROUD, T ;
SIEMERS, E ;
KLEINDORFER, D ;
BILL, DJ ;
HODES, ME ;
NORTON, JA ;
CONNEALLY, PM ;
CHRISTIAN, JC .
ANNALS OF NEUROLOGY, 1995, 37 (05) :657-664
[10]   Differences in duration of Huntington's disease based on age at onset [J].
Foroud, T ;
Gray, J ;
Ivashina, J ;
Conneally, PM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (01) :52-56